|
WO2010102673A1
|
|
Hellebrin and hellebrigenin derivatives
|
|
US2009232907A1
|
|
Compositions and methods for treatment of esophageal cancer
|
|
US2009186915A1
|
|
Compositions and methods for treatment of glioblastoma, gliosarcoma, NSCLC, and head and neck cancer
|
|
US2009221628A1
|
|
Compositions and methods for treatment of prostate and breast cancer
|
|
US2008261935A1
|
|
2″ oxo-voruscharin and derivatives thereof
|
|
MX2009003728A
|
|
New isocarbostyril alkaloid derivatives having anti-proliferative and anti-migratory activities.
|
|
EP2089395A2
|
|
New isocarbostyril alkaloid derivatives having anti-proliferative and anti-migratory activities
|
|
WO2009033505A1
|
|
Hellebrin derivatives
|
|
KR20090026141A
|
|
5-urea substituted naphthalimide derivatives, methods of production and pharmaceutical compositions for treating cancer
|
|
CN101479247A
|
|
5-urea substituted naphthalimide derivatives, methods of production and pharmaceutical compositions for treating cancer
|
|
AU2006350507A1
|
|
Targeting of alpha-1 or alpha-3 subunit of Na+, K+-ATPase in the treatment of proliferative diseases
|
|
ZA200605900B
|
|
Glycosylated steroid derivatives with anti-migratory activity
|
|
GB0608900D0
|
|
Naphthalimide derivatives, methods for their production and pharmaceutical compositions therefrom
|
|
ZA200803875B
|
|
Azonafide derivatives, methods for their production and pharmaceutical compositions therefrom
|
|
EP1787985A1
|
|
Azonafide derivatives, methods for their production and pharmaceutical compositions therefrom
|
|
ZA200607620B
|
|
Naphthalimide derivatives, methods for their production and pharmaceutical composition therefrom
|
|
AU2005238096A1
|
|
Naphthalimide derivatives, methods for their production and pharmaceutical compositions therefrom
|
|
WO2005058934A2
|
|
Glycosylated steroid derivatives with anti-migratory activity
|
|
EP1572715A1
|
|
Steroid compounds with anti-tumor activity
|
|
MXPA05003633A
|
|
2" oxo-voruscharin and derivatives thereof.
|
